NAP
New Amsterdam Partners’s Emergent Biosolutions EBS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $6.23M | Sell |
123,288
-73,789
| -37% | -$3.73M | 2.29% | 10 |
|
|
2018
Q4 | $11.7M | Sell |
197,077
-13,559
| -6% | -$804K | 3.85% | 1 |
|
|
2018
Q3 | $13.9M | Sell |
210,636
-25,325
| -11% | -$1.67M | 3.56% | 1 |
|
|
2018
Q2 | $11.9M | Sell |
235,961
-28,605
| -11% | -$1.44M | 2.82% | 4 |
|
|
2018
Q1 | $13.9M | Buy |
264,566
+3,195
| +1% | +$168K | 3.04% | 3 |
|
|
2017
Q4 | $12.1M | Buy |
261,371
+98,034
| +60% | +$4.56M | 2.43% | 6 |
|
|
2017
Q3 | $6.61M | Buy |
163,337
+65,109
| +66% | +$2.63M | 1.38% | 26 |
|
|
2017
Q2 | $3.33M | Buy |
+98,228
| New | +$3.33M | 0.71% | 56 |
|
|
2016
Q4 | – | Sell |
-145,797
| Closed | -$4.6M | – | 130 |
|
|
2016
Q3 | $4.6M | Buy |
145,797
+37,535
| +35% | +$1.18M | 1.06% | 42 |
|
|
2016
Q2 | $3.04M | Sell |
108,262
-1,331
| -1% | -$37.4K | 0.74% | 59 |
|
|
2016
Q1 | $3.98M | Buy |
+109,593
| New | +$3.98M | 0.42% | 66 |
|
|
2015
Q2 | – | Sell |
-136,116
| Closed | -$3.92M | – | 120 |
|
|
2015
Q1 | $3.92M | Sell |
136,116
-37,787
| -22% | -$1.09M | 0.32% | 73 |
|
|
2014
Q4 | $4.74M | Buy |
173,903
+14,433
| +9% | +$393K | 0.41% | 53 |
|
|
2014
Q3 | $3.4M | Buy |
159,470
+21,718
| +16% | +$463K | 0.23% | 81 |
|
|
2014
Q2 | $3.09M | Buy |
137,752
+32,118
| +30% | +$721K | 0.2% | 92 |
|
|
2014
Q1 | $2.67M | Buy |
+105,634
| New | +$2.67M | 0.18% | 93 |
|